These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11010591)

  • 1. Polystyrene microsphere spray standards based on CFC-free inhaler technology.
    Vervaet C; Byron PR
    J Aerosol Med; 2000; 13(2):105-15. PubMed ID: 11010591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized dose delivery of the peptide cyclosporine using hydrofluoroalkane-based metered dose inhalers.
    Myrdal PB; Karlage KL; Stein SW; Brown BA; Haynes A
    J Pharm Sci; 2004 Apr; 93(4):1054-61. PubMed ID: 14999741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of a protein with propellant HFA 134a for aerosol delivery.
    Williams RO; Liu J
    Eur J Pharm Sci; 1999 Jan; 7(2):137-44. PubMed ID: 9845798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
    Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
    Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-surfactant-propellant interactions in HFA-formulations.
    Vervaet C; Byron PR
    Int J Pharm; 1999 Sep; 186(1):13-30. PubMed ID: 10469920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of reduction of propellant mass fraction on the injection profile of metered dose inhalers.
    Ju D; Shrimpton J; Hearn A
    Int J Pharm; 2010 May; 391(1-2):221-9. PubMed ID: 20227471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility evaluation of metered-dose inhaler valve elastomers with tetrafluoroethane (P134a), a non-CFC propellant.
    Tiwari D; Goldman D; Dixit S; Malick WA; Madan PL
    Drug Dev Ind Pharm; 1998 Apr; 24(4):345-52. PubMed ID: 9876594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions.
    Dalby RN; Byron PR
    Pharm Res; 1988 Jan; 5(1):36-9. PubMed ID: 3244606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the metering chamber volume and actuator design on the aerodynamic particle size of a metered dose inhaler.
    Berry J; Heimbecher S; Hart JL; Sequeira J
    Drug Dev Ind Pharm; 2003 Sep; 29(8):865-76. PubMed ID: 14570307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Malvern Spraytec with inhalation cell for the measurement of particle size distribution from metered dose inhalers.
    Haynes A; Shaik MS; Krarup H; Singh M
    J Pharm Sci; 2004 Feb; 93(2):349-63. PubMed ID: 14705192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrafluoroethane (HFC 134A) propellant-driven aerosols of proteins.
    Brown AR; George DW
    Pharm Res; 1997 Nov; 14(11):1542-7. PubMed ID: 9434272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particle size study of nine metered dose inhalers, and their deposition probabilities in the airways.
    Bouchikhi A; Becquemin MH; Bignon J; Roy M; Teillac A
    Eur Respir J; 1988 Jun; 1(6):547-52. PubMed ID: 3169224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of reformulation.
    Smith IJ
    J Aerosol Med; 1995; 8 Suppl 1():S19-27. PubMed ID: 10150491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the evaporation of metered-dose inhaler formulations in humid air: single droplet experiments.
    Martin AR; Kwok DY; Finlay WH
    J Aerosol Med; 2005; 18(2):218-24. PubMed ID: 15966776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and evaluation of albuterol metered dose inhalers containing tetrafluoroethane (P134a), a non-CFC propellant.
    Tiwari D; Goldman D; Malick WA; Madan PL
    Pharm Dev Technol; 1998 May; 3(2):163-74. PubMed ID: 9653753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size analysis of a pressurized metered dose inhaler-delivered solution formulation by an Aerosizer-LD time-of-flight aerosol particle size spectrometer.
    Nagel MW; Wiersema KJ; Bates SL; Mitchell JP
    J Aerosol Med; 2002; 15(1):75-85. PubMed ID: 12006148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues surrounding MDI formulation development with non-CFC propellants.
    Kontny MJ; Destefano G; Jager PD; McNamara DP; Turi JS; Van Campen L
    J Aerosol Med; 1991; 4(3):181-7. PubMed ID: 10147677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
    Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.